Asthenozoospermia: Cellular and molecular contributing factors and treatment strategies
- 3 November 2019
- journal article
- review article
- Published by Hindawi Limited in Andrologia
- Vol. 52 (2), e13463
- https://doi.org/10.1111/and.13463
Abstract
Semen sample with poor sperm motility, which called asthenozoospermia, is considered as one of the main factors contributing to male infertility. Recognition of the cellular and molecular pathways contributing to sperm motility reduction may lead to applying novel treatment strategies for overcoming low sperm motility in asthenozoospermia individuals. In this review, we intend to discuss the main causes of sperm motility reduction in asthenozoospermia and some treatment strategies used to overcome low sperm motility.Keywords
This publication has 90 references indexed in Scilit:
- Ion Channels in Sperm Physiology and Male Fertility and InfertilityJournal of Andrology, 2012
- Selenium–vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rateInternational Journal of General Medicine, 2011
- TMF/ARA160: A key regulator of sperm developmentDevelopmental Biology, 2010
- Genetic male infertility and mutation of CATSPER ion channelsEuropean Journal of Human Genetics, 2010
- Genetic vasectomy—Overexpression of Prm1‐EGFP fusion protein in elongating spermatids causes dominant male sterility in micegenesis, 2010
- PICK1 deficiency causes male infertility in mice by disrupting acrosome formationJCI Insight, 2009
- Mammalian sperm metabolism: oxygen and sugar, friend and foeThe International Journal of Developmental Biology, 2008
- Mutation of β-glucosidase 2 causes glycolipid storage disease and impaired male fertilityJCI Insight, 2006
- Loss of TSLC1 Causes Male Infertility Due to a Defect at the Spermatid Stage of SpermatogenesisMolecular and Cellular Biology, 2006
- The microtubule plus-end-tracking protein CLIP-170 associates with the spermatid manchette and is essential for spermatogenesisGenes & Development, 2005